O'Neill Brian, Tilley Michael R, Han Dawn D, Thirtamara-Rajamani Keerthi, Hill Erik R, Bishop Georgia A, Zhou Fu-Ming, During Matthew J, Gu Howard H
Department of Pharmacology, The Ohio State University, 333 West 10th Avenue, 5184B Graves Hall, Columbus, OH 43210, USA; Neuroscience Graduate Studies Program, The Ohio State University, Columbus, OH 43210, USA.
Department of Pharmacology, The Ohio State University, 333 West 10th Avenue, 5184B Graves Hall, Columbus, OH 43210, USA.
Neuropharmacology. 2014 Apr;79:626-33. doi: 10.1016/j.neuropharm.2013.12.023. Epub 2014 Jan 9.
Cocaine's main pharmacological actions are the inhibition of the dopamine, serotonin, and norepinephrine transporters. Its main behavioral effects are reward and locomotor stimulation, potentially leading to addiction. Using knock-in mice with a cocaine-insensitive dopamine transporter (DAT-CI mice) we have shown previously that inhibition of the dopamine transporter (DAT) is necessary for both of these behaviors. In this study, we sought to determine brain regions in which DAT inhibition by cocaine stimulates locomotor activity and/or produces reward. We used adeno-associated viral vectors to re-introduce the cocaine-sensitive wild-type DAT in specific brain regions of DAT-CI mice, which otherwise only express a cocaine-insensitive DAT globally. Viral-mediated expression of wild-type DAT in the rostrolateral striatum restored cocaine-induced locomotor stimulation and sensitization in DAT-CI mice. In contrast, the expression of wild-type DAT in the dorsal striatum, or in the medial nucleus accumbens, did not restore cocaine-induced locomotor stimulation. These data help to determine cocaine's molecular actions and anatomical loci that cause hyperlocomotion. Interestingly, cocaine did not produce significant reward - as measured by conditioned place-preference - in any of the three cohorts of DAT-CI mice with the virus injections. Therefore, the locus or loci underlying cocaine-induced reward remain underdetermined. It is possible that multiple dopamine-related brain regions are involved in producing the robust rewarding effect of cocaine.
可卡因的主要药理作用是抑制多巴胺、5-羟色胺和去甲肾上腺素转运体。其主要行为效应是奖赏和运动刺激,可能导致成瘾。我们之前使用携带对可卡因不敏感的多巴胺转运体的敲入小鼠(DAT-CI小鼠)证明,多巴胺转运体(DAT)的抑制对于这两种行为都是必需的。在本研究中,我们试图确定可卡因对DAT的抑制作用能刺激运动活性和/或产生奖赏的脑区。我们使用腺相关病毒载体在DAT-CI小鼠的特定脑区重新引入对可卡因敏感的野生型DAT,否则这些小鼠仅在整体上表达对可卡因不敏感的DAT。病毒介导的野生型DAT在吻侧外侧纹状体中的表达恢复了DAT-CI小鼠中可卡因诱导的运动刺激和敏化。相比之下,野生型DAT在背侧纹状体或伏隔核内侧的表达并未恢复可卡因诱导的运动刺激。这些数据有助于确定可卡因导致运动亢进的分子作用和解剖位点。有趣的是,在注射病毒的三组DAT-CI小鼠中,可卡因均未产生显著的奖赏作用(通过条件性位置偏爱测量)。因此,可卡因诱导奖赏的位点仍未确定。多个与多巴胺相关的脑区可能参与产生可卡因强大的奖赏效应。